Clinical Trials Logo

Clinical Trial Summary

Recent studies report that as few as 44% of athletes undergoing ACL reconstruction were able to return to their prior level of competitive level of sports. Early return may predispose an individual to re-injury including graft re-tear, meniscal tears, chondral injuries, and contralateral knee injuries. Criteria governing clearance to return to sports after ACL reconstruction has been traditionally defined using time from surgery and one or two objective criteria, often solely isokinetic quad/hamstring strength. Several studies have suggested that historical criteria used to assess readiness to return to play (RTP) are insufficient in identifying individuals at risk of a re-injury. They advocate for additional functional and dynamic testing, which may better reflect the complex kinematics required in high level athletic competition. We previously developed a "Safe Return to Play Following ACL Reconstruction Checklist" based on a systematic review of the literature and expert survey. Seven objective measures were developed as part of the checklist. The checklist is performed by a certified physical therapist trained in these performance tests. The purpose of this study is to validate the utility of our "Return to Play Checklist" by evaluating our patients prospectively for return to play following ACL reconstruction by comparing a cohort of patient undergoing testing with the checklist versus "clinical judgement."


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • ACL Tear
  • Anterior Cruciate Ligament Injuries

NCT number NCT04827264
Study type Observational
Source Rothman Institute Orthopaedics
Contact
Status Completed
Phase
Start date February 20, 2016
Completion date February 20, 2020

See also
  Status Clinical Trial Phase
Completed NCT02450292 - Retrospective CT Imaging of BioComposite Interference Screw With BTB
Recruiting NCT05912777 - 3D Reconstruction of the Knee Based on MRI N/A
Recruiting NCT04058574 - Proprioceptive Isokinetic Repositioning, Functional Testing, and a Self-reported Questionnaire Before and After Anterior Cruciate Ligament Reconstruction N/A
Recruiting NCT06274008 - Exparel vs. ACB With Bupivacaine for ACL Reconstruction Phase 1
Active, not recruiting NCT05338385 - Readiness Outcomes Affecting Return to Sport 2.0: An Intervention Feasibility & Pilot Study N/A
Enrolling by invitation NCT05931627 - Tourniquet Use in Anterior Cruciate Ligament Repair N/A
Not yet recruiting NCT06340932 - Impact of Opioid Avoidance Protocol for ACL Reconstruction
Completed NCT04484961 - Effects of Blood Flow Restriction Rehabilitation After Anterior Cruciate Ligament Reconstruction N/A
Completed NCT05876013 - Reduced Knee Flexion Strength 18 Years After ACL Reconstruction in Hamstring Group Compared to Patellar Tendon Group
Recruiting NCT04748328 - Comparison Effectiveness Analysis Between ACL Reconstruction and Rehabilitation in Peripheral and Main Capital in Indonesia
Recruiting NCT04732585 - Kinematic Assessment of Human Peripheral Joints by Dynamic CT N/A
Completed NCT03243162 - Improving ACL Reconstruction Outcomes: CBPT N/A
Recruiting NCT06235736 - Do Patients With ACL Tears Demonstrate Weakness of the Soleus Muscle?
Not yet recruiting NCT06063915 - Isoinertial Rehabilitation in Recovering Hamstring Strength Following Surgical Anterior Cruciate Ligament Reconstruction N/A
Recruiting NCT04550299 - ACL Reconstruction With Simple and Double Bundle Technique Using Two Different Implants for Graft Fixation N/A
Not yet recruiting NCT04721119 - Comparing Adductor Canal Block and Adductor Canal Block-Local Infiltration Analgesia for Post-operative Pain Management N/A
Recruiting NCT04682392 - ACL Bone Health and Loading Study N/A
Recruiting NCT05241795 - Knee vs. Ankle Training on Knee Mechanics After ACLR N/A
Not yet recruiting NCT05532189 - Anterior Cruciate Ligament (ACL) Reconstruction With Bone Tendon Bone Autograft With Versus Without Internal Bracing N/A
Not yet recruiting NCT06096259 - Preventing Injured Knees From osteoArthritis: Severity Outcomes Phase 2